Cereno Scientific
M├╢lndal
About Cereno Scientific
Cereno Scientific AB develops a new innovative treatment for patients with increased risk of blood clotting, based on the company's newly patented research findings. Cereno Scientific AB develops drugs that normalize the body's own defense system against blood clots for the treatment of complications in cardiovascular diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $86.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: sto:CRNO-B
- Website: cerenoscientific.com
- Phone: +46 732 366 246
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cereno-scientific-64379 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.